Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Five-year outcomes after a change from a cyclosporin-based to a 'low-dose' tacrolimus-based primary immunosuppression regimen for incident kidney transplants--the Glasgow experience.

Geddes CC, Jardine AG, Kingsmore D, Murio E, Buist L, Shumeyko V, Padmanabhan N, Daly C, McGregor E, McMillan M, McManus S, Rodger RS, Clancy M.

Clin Transpl. 2012:95-102.

PMID:
23721012
[PubMed - indexed for MEDLINE]
2.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
[PubMed - indexed for MEDLINE]
3.

BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen.

Geddes CC, Gunson R, Mazonakis E, Wan R, Thomson L, Clancy M, Carman WF.

Transpl Infect Dis. 2011 Apr;13(2):109-16. doi: 10.1111/j.1399-3062.2010.00566.x. Epub 2010 Sep 7.

PMID:
21457419
[PubMed - indexed for MEDLINE]
4.

Improved solitary pancreas transplant graft survival in the modern immunosuppressive era.

Odorico JS, Becker YT, Groshek M, Werwinski C, Becker BN, Pirsch JD, Sollinger HW.

Cell Transplant. 2000 Nov-Dec;9(6):919-27.

PMID:
11202579
[PubMed - indexed for MEDLINE]
5.

The effect of maintenance immunosuppression medication on the change in kidney allograft function.

Gill JS, Tonelli M, Mix CH, Johnson N, Pereira BJ.

Kidney Int. 2004 Feb;65(2):692-9.

PMID:
14717943
[PubMed - indexed for MEDLINE]
6.

Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.

Tsai MK, Wu FL, Lai IR, Lee CY, Hu RH, Lee PH.

Int J Artif Organs. 2009 Jun;32(6):371-80.

PMID:
19670189
[PubMed - indexed for MEDLINE]
7.

A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.

Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.

Transplantation. 2012 Feb 27;93(4):437-43. doi: 10.1097/TP.0b013e31824215b7.

PMID:
22228415
[PubMed - indexed for MEDLINE]
8.

New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.

Ulsh PJ, Yang HC, Holman MJ, Ahsan N.

J Transpl Coord. 1999 Jun;9(2):114-8.

PMID:
10703393
[PubMed - indexed for MEDLINE]
9.

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.

Ahsan N, Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.

Transplantation. 2001 Jul 27;72(2):245-50.

PMID:
11477347
[PubMed - indexed for MEDLINE]
10.

The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.

Pham PT, Pham PC.

Nephrol Dial Transplant. 2012 Jul;27(7):2965-71. doi: 10.1093/ndt/gfr731. Epub 2011 Dec 29.

PMID:
22207327
[PubMed - indexed for MEDLINE]
Free Article
11.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

PMID:
15899149
[PubMed - indexed for MEDLINE]
Free Article
12.

A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.

Cherikh WS, Myron Kauffman H, Maghirang J, Bleyer AJ, Johnson CP.

Transplantation. 2003 Aug 15;76(3):463-70.

PMID:
12923430
[PubMed - indexed for MEDLINE]
13.

Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody.

Gonwa TA, Mai ML, Smith LB, Levy MF, Goldstein RM, Klintmalm GB.

Clin Transplant. 2002 Apr;16(2):144-9.

PMID:
11966785
[PubMed - indexed for MEDLINE]
14.

Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.

Bakr MA, Gheith OA, Ismael AM, Baz ME, Shehab El-Dein AB, Ghoneim MA.

Exp Clin Transplant. 2008 Mar;6(1):48-53.

PMID:
18405245
[PubMed - indexed for MEDLINE]
Free Article
15.

Mycophenolate mofetil in pancreas transplantation.

Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC.

Transplantation. 1998 Aug 15;66(3):318-23.

PMID:
9721799
[PubMed - indexed for MEDLINE]
16.

Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.

Gruessner RW.

Clin Transplant. 1997 Aug;11(4):299-312.

PMID:
9267719
[PubMed - indexed for MEDLINE]
17.

A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year.

Mendez R, Gonwa T, Yang HC, Weinstein S, Jensik S, Steinberg S; Prograf Study Group.

Transplantation. 2005 Aug 15;80(3):303-9.

PMID:
16082323
[PubMed - indexed for MEDLINE]
18.

Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.

Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, Reichart B, Hagl C, Kaczmarek I.

Transplantation. 2013 Feb 27;95(4):629-34. doi: 10.1097/TP.0b013e318277e378.

PMID:
23423270
[PubMed - indexed for MEDLINE]
19.

Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era.

Gralla J, Wiseman AC.

Transplantation. 2009 Jun 15;87(11):1712-9. doi: 10.1097/TP.0b013e3181a60431.

PMID:
19502965
[PubMed - indexed for MEDLINE]
20.

Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.

Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K.

Transplantation. 2012 Sep 15;94(5):492-8.

PMID:
22858806
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk